Elevated Id2 expression results in precocious neural stem cell depletion and abnormal brain development

Stem Cells

Volumn 31, Issue 5, 2013, Pages 1010-1021

  Park, Hee Jung ^a   Hong, Mingi ^a   Bronson, Roderick T ^b   Israel, Mark A ^c   Frankel, Wayne N ^a   Yun, Kyuson ^a  

^a JACKSON LABORATORY   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Brain tumor; CyclinG1; Glioma; Id2; Medulloblastoma; Neural stem cells; Rett syndrome; Seizure; Self renewal

Indexed keywords

CYCLIN G1; INHIBITOR OF DIFFERENTIATION 2; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL LOSS; CELL PROLIFERATION; CELL RENEWAL; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; FEMALE; G2 PHASE CELL CYCLE CHECKPOINT; MALE; MICROCEPHALY; MOUSE; NEURAL STEM CELL; NEUROEPITHELIUM; NONHUMAN; PROTEIN EXPRESSION; TONIC CLONIC SEIZURE;

ANIMALS; BRAIN; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; INHIBITOR OF DIFFERENTIATION PROTEIN 2; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURAL STEM CELLS;

MUS;

EID: 84876554264     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1351     Document Type: Article

References (52)

1. Temple S. The development of neural stem cells. Nature 2001;414:112-117. (Pubitemid 33041635)
2. Gotz M, Huttner WB. The cell biology of neurogenesis. Nat Rev Mol Cell Biol 2005;6:777-788. (Pubitemid 41726116)
3. Kageyama R, Ohtsuka T, Hatakeyama J et al. Roles of bHLH genes in neural stem cell differentiation. Exp Cell Res 2005;306:343-348. (Pubitemid 40732759)
4. Schuurmans C, Guillemot F. Molecular mechanisms underlying cell fate specification in the developing telencephalon. Curr Opin Neurobiol 2002;12:26-34. (Pubitemid 34175271)
5. Yun K, Mantani A, Garel S et al. Id4 regulates neural progenitor proliferation and differentiation in vivo. Development 2004;131:5441-5448. (Pubitemid 39562186)
6. Lyden D, Young AZ, Zagzag D et al. Id1 and Id3 are required for neurogenesis, angiogenesis, and vascularization of tumor xenografts. Nature 1999;401:670-677.
7. Peddada S, Yasui DH, Lasalle JM. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome. Hum Mol Genet 2006;15:2003-2014. (Pubitemid 43983274)
8. Perk J, Iavarone A, Benezra R. Id family of helix-loop-helix proteins in cancer. Nat Rev Cancer 2005;5:603-614. (Pubitemid 41081386)
9. Benezra R, Davis RL, Lockshon D et al. The protein Id: A negative regulator of helix-loop-helix DNA binding proteins. Cell 1990;61:49-59.
10. Ruzinova MB, Benezra R. Id proteins in development, cell cycle and cancer. Trends Cell Biol 2003;13:410-418. (Pubitemid 36897645)
11. Lasorella A, Noseda M, Beyna M et al. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature 2000;407:592-598.
12. Lasorella A, Rothschild G, Yokota Y et al. Id2 mediates tumor initiation, proliferation, and angiogenesis in Rb mutant mice. Mol Cell Biol 2005;25:3563-3574. (Pubitemid 40559563)
13. Jen Y, Manova K, Benezra R. Each member of the Id gene family exhibits a unique expression pattern in mouse gastrulation and neurogenesis. Dev Dyn 1997;208:92-106. (Pubitemid 27030487)
14. Neuman T, Keen A, Zuber MX et al. Neuronal expression of regulatory helix-loop-helix factor Id2 gene in mouse. Dev Biol 1993;160:186-195. (Pubitemid 23344240)
15. Rubenstein JL, Anderson S, Shi L et al. Genetic control of cortical regionalization and connectivity. Cereb Cortex 1999;9:524-532. (Pubitemid 29441493)
16. Yu P, Zhang YP, Shields LB et al. Inhibitor of DNA binding 2 promotes sensory axonal growth after SCI. Exp Neurol 2011;231:38-44.
17. Lasorella A, Stegmuller J, Guardavaccaro D et al. Degradation of Id2 by the anaphase-promoting complex couples cell cycle exit and axonal growth. Nature 2006;442:471-474. (Pubitemid 44264798)
18. Ying QL, Nichols J, Chambers I et al. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 2003;115:281-292. (Pubitemid 37487702)
19. Nam HS, Benezra R. High levels of Id1 expression define B1 type adult neural stem cells. Cell Stem Cell 2009;5:515-526.
20. Anido J, Saez-Borderias A, Gonzalez-Junca A et al. TGF-beta receptor inhibitors target the CD44(high)/Id1(high) glioma-initiating cell population in human glioblastoma. Cancer Cell 2010;18:655-668.
21. Jeon HM, Jin X, Lee JS et al. Inhibitor of differentiation 4 drives brain tumor-initiating cell genesis through cyclin E and notch signaling. Genes Dev 2008;22:2028-2033.
22. Russell RG, Lasorella A, Dettin LE et al. Id2 drives differentiation and suppresses tumor formation in the intestinal epithelium. Cancer Res 2004;64:7220-7225. (Pubitemid 39372055)
23. Yan W, Liu G, Scoumanne A et al. Suppression of inhibitor of differentiation 2, a target of mutant p53, is required for gain-of-function mutations. Cancer Res 2008;68:6789-6796.
24. Parrinello S, Lin CQ, Murata K et al. Id-1, ITF-2, and Id-2 comprise a network of helix-loop-helix proteins that regulate mammary epithelial cell proliferation, differentiation, and apoptosis. J Biol Chem 2001;276:39213-39219.
25. Florio M, Hernandez MC, Yang H et al. Id2 promotes apoptosis by a novel mechanism independent of dimerization to basic helix-loop-helix factors. Mol Cell Biol 1998;18:5435-5444. (Pubitemid 28388126)
26. Paolella BR, Havrda MC, Mantani A et al. p53 directly represses Id2 to inhibit the proliferation of neural progenitor cells. Stem Cells 2011;29:1090-1101.
27. Frankel WN, Taylor L, Beyer B et al. Electroconvulsive thresholds of inbred mouse strains. Genomics 2001;74:306-312. (Pubitemid 32675354)
28. Yang Y, Mahaffey CL, Berube N et al. Complex seizure disorder caused by Brunol4 deficiency in mice. Plos Genetics 2007;3:e124.
29. Hébert JM, McConnell SK. Targeting of cre to the Foxg1 (BF-1) locus mediates loxP recombination in the telencephalon and other developing head structures. Dev Biol 2000;222:296-306. (Pubitemid 30416368)
30. Yun K, Potter S, Rubenstein JL. Gsh2 and Pax6 play complementary roles in dorsoventral patterning of the mammalian telencephalon. Development 2001;128:193-205. (Pubitemid 32124145)
31. Englund C, Fink A, Lau C et al. Pax6, Tbr2, and Tbr1 are expressed sequentially by radial glia, intermediate progenitor cells, and postmitotic neurons in developing neocortex. J Neurosci 2005;25:247-251. (Pubitemid 40110787)
32. Havrda MC, Harris BT, Mantani A et al. Id2 is required for specification of dopaminergic neurons during adult olfactory neurogenesis. J Neurosci 2008;28:14074-14086.
33. Quinones HI, Savage TK, Battiste J et al. Neurogenin 1 (Neurog1) expression in the ventral neural tube is mediated by a distinct enhancer and preferentially marks ventral interneuron lineages. Dev Biol 2010;340:283-292.
34. Kim EJ, Hori K, Wyckoff A et al. Spatiotemporal fate map of neurogenin1 (Neurog1) lineages in the mouse central nervous system. J Comp Neurol 2011;519:1355-1370.
35. Sauer FC. Mitosis in the neural tube. J Comp Neurol 1935;62:377-405.
36. Meletis K, Wirta V, Hede SM et al. p53 suppresses the self-renewal of adult neural stem cells. Development 2006;133:363-369. (Pubitemid 43210724)
37. Armesilla-Diaz A, Bragado P, Del Valle I et al. p53 regulates the self-renewal and differentiation of neural precursors. Neuroscience 2009;158:1378-1389.
38. Stecca B, Ruiz i Altaba A. A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers. EMBO J 2009;28:663-676.
39. Andres-Barquin PJ, Hernandez MC, Hayes TE et al. Id genes encoding inhibitors of transcription are expressed during in vitro astrocyte differentiation and in cell lines derived from astrocytic tumors. Cancer Res 1997;57:215-220. (Pubitemid 27036596)
40. Iavarone A, Lasorella A. Id proteins in neural cancer. Cancer Lett 2004;204:189-196. (Pubitemid 38167722)
41. Mikami S, Hirose Y, Yoshida K et al. Predominant expression of OLIG2 over ID2 in oligodendroglial tumors. Virchows Arch 2007;450:575-584. (Pubitemid 46676246)
42. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008;455:1061-1068.
43. Harvey M, McArthur MJ, Montgomery CA, Jr. et al. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat Genet 1993;5:225-229. (Pubitemid 23330383)
44. Halazonetis TD, Gorgoulis VG, Bartek J. An oncogene-induced DNA damage model for cancer development. Science 2008;319:1352-1355. (Pubitemid 351354863)
45. Bartkova J, Horejsi Z, Koed K et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005;434:864-870. (Pubitemid 40558993)
46. Bartkova J, Rezaei N, Liontos M et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006;444:633-637. (Pubitemid 44864442)
47. Lukaszewicz AI, Anderson DJ. Cyclin D1 promotes neurogenesis in the developing spinal cord in a cell cycle-independent manner. Proc Natl Acad Sci USA 2011;108:11632-11637.
48. Jung S, Park RH, Kim S et al. Id proteins facilitate self-renewal and proliferation of neural stem cells. Stem Cells Dev 2010;19:831-841.
49. Toma JG, El-Bizri H, Barnabe-Heider F et al. Evidence that helix-loop-helix proteins collaborate with retinoblastoma tumor suppressor protein to regulate cortical neurogenesis. J Neurosci 2000;20:7648-7656.
50. Iavarone A, Garg P, Lasorelle A et al. The helix-loop-helix protein Id2 enhances cell proliferation and binds to the retinoblastoma protein. Genes Dev 1994;8:1270-1284.
51. de Bruin A, Wu L, Saavedra HI et al. Rb function in extraembryonic lineages suppresses apoptosis in the CNS of Rb-deficient mice. Proc Natl Acad Sci USA 2003;100:6546-6551. (Pubitemid 36666618)
52. MacPherson D, Sage J, Crowley D et al. Conditional mutation of Rb causes cell cycle defects without apoptosis in the central nervous system. Mol Cell Biol 2003;23:1044-1053. (Pubitemid 36133520)